Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Feb;83(2):210–214. doi: 10.1111/j.1365-2249.1991.tb05616.x

Hepatitis B surface antigen induces an early-type hypersensitivity.

H Y Lei 1, J Y Wang 1, T T Chang 1, C C Wang 1
PMCID: PMC1535262  PMID: 1993355

Abstract

In addition to the delayed-type hypersensitivity (DTH), a unique type of hypersensitivity could be induced at a late stage of the immune responses after hepatitis B surface antigen (HBsAg) immunization. This antigen-specific ear swelling that develops within 1 h after antigen challenge has been referred to as the early-type hypersensitivity (ETH) in contrast to the 24-h DTH. Although expression of ETH was earlier than DTH, the induction of the former needed 3 days longer than that of the latter. In ETH, the plasma protein leaked into the tissue and the vasopermeability increased within 15 min, causing the oedema of ETH. The observation that cyproheptadine, not dexamethasone, inhibited ETH suggests that it is mediated through the release of histamine and/or serotonin. Furthermore, ETH could be transferred by immune sera. Heat treatment (56 C for 4 h) did not destroy the transfer, suggesting that it was not mediated by IgE. The human anti-HBs sera from either hepatitis B virus infection or HBsAg vaccinee also contained the activity to transfer the ETH in mice.

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen D. S., Hsu N. H., Sung J. L., Hsu T. C., Hsu S. T., Kuo Y. T., Lo K. J., Shih Y. T. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987 May 15;257(19):2597–2603. [PubMed] [Google Scholar]
  2. Claman H. N., Miller S. D., Sy M. S., Moorhead J. W. Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev. 1980;50:105–132. doi: 10.1111/j.1600-065x.1980.tb00309.x. [DOI] [PubMed] [Google Scholar]
  3. De Moerloose P. A., Frazer I. H., Sewell W. A., Collins E. J., Mackay I. R. Cell-mediated immunity to hepatitis B virus antigens in mice: correlation of in vivo and in vitro assays. Clin Exp Immunol. 1986 May;64(2):285–294. [PMC free article] [PubMed] [Google Scholar]
  4. Hirasawa N., Ohuchi K., Sugio K., Tsurufuji S., Watanabe M., Yoshino S. Vascular permeability responses and the role of prostaglandin E2 in an experimental allergic inflammation of air pouch type in rats. Br J Pharmacol. 1986 Apr;87(4):751–756. doi: 10.1111/j.1476-5381.1986.tb14593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hirasawa N., Ohuchi K., Watanabe M., Tsurufuji S. Role of endogenous histamine in postanaphylactic phase of allergic inflammation in rats. J Pharmacol Exp Ther. 1987 Jun;241(3):967–973. [PubMed] [Google Scholar]
  6. Inagaki N., Nagai H., Koda A. Comparative study of IgG1 and IgE antibody mediated homologous PCA in the mouse ear. Lack of cross-desensitization of IgG1 antibody mediated PCA to IgE antibody mediated PCA. Int Arch Allergy Appl Immunol. 1988;86(3):325–330. doi: 10.1159/000234592. [DOI] [PubMed] [Google Scholar]
  7. Jenkins M. K., Lei H. Y., Waltenbaugh C., Miller S. D. Immunoregulatory pathways in adult responder mice. I. Induction of GAT-specific tolerance and suppressor T cells for cellular and humoral responses. Scand J Immunol. 1984 Jun;19(6):501–512. doi: 10.1111/j.1365-3083.1984.tb00961.x. [DOI] [PubMed] [Google Scholar]
  8. Lei H. Y., Huang K. J., Shen C. L., Huang J. L. An antigen-specific hypersensitivity which does not fit into traditional classification of hypersensitivity. J Immunol. 1989 Jul 15;143(2):432–438. [PubMed] [Google Scholar]
  9. Lei H. Y., Lee S. C. Igh allotype-linked control of immune complex-type hypersensitivity induced by hepatitis B surface antigen. Immunology. 1989 Dec;68(4):458–463. [PMC free article] [PubMed] [Google Scholar]
  10. Lei H. Y., Melvold R. W., Miller S. D., Waltenbaugh C. Gain/loss of poly(Glu50Tyr50)/poly(Glu60Ala30Tyr10) responsiveness in the bm12 mutant strain. J Exp Med. 1982 Aug 1;156(2):596–609. doi: 10.1084/jem.156.2.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McAuliffe V. J., Purcell R. H., Gerin J. L. Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev Infect Dis. 1980 May-Jun;2(3):470–492. doi: 10.1093/clinids/2.3.470. [DOI] [PubMed] [Google Scholar]
  12. Milich D. R., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982 Jul;129(1):320–325. [PubMed] [Google Scholar]
  13. Milich D. R., Leroux-Roels G. G., Louie R. E., Chisari F. V. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions. J Exp Med. 1984 Jan 1;159(1):41–56. doi: 10.1084/jem.159.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ohuchi K., Hirasawa N., Watanabe M., Tsurufuji S. Pharmacological analysis of the vascular permeability response in the anaphylactic phase of allergic inflammation in rats. Eur J Pharmacol. 1985 Nov 19;117(3):337–345. doi: 10.1016/0014-2999(85)90007-x. [DOI] [PubMed] [Google Scholar]
  15. Skelly J., Howard C. R., Zuckerman A. J. The labelling of galactose residues in hepatitis B surface antigen glycoprotein. J Gen Virol. 1978 Dec;41(3):447–457. doi: 10.1099/0022-1317-41-3-447. [DOI] [PubMed] [Google Scholar]
  16. Van Loveren H., Askenase P. W. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J Immunol. 1984 Nov;133(5):2397–2401. [PubMed] [Google Scholar]
  17. Yoshino S., Ohuchi K., Tsurufuji S. Induction of a delayed type hypersensitivity to carrageenin in mice. J Pharmacobiodyn. 1982 Apr;5(4):266–272. doi: 10.1248/bpb1978.5.266. [DOI] [PubMed] [Google Scholar]
  18. van Loveren H., Meade R., Askenase P. W. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med. 1983 May 1;157(5):1604–1617. doi: 10.1084/jem.157.5.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES